Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2045

Annual patent cliff calendar for 2045 — US pharmaceutical patents by expiration date.

Patents
1,566

Quick answer

1,566 indexed pharmaceutical patents have expiration dates in 2045. Browse by soonest expiry with links to assignee companies and related drugs.

  1. WO 2025247801

    DÉTERMINATION D'UN DOSAGE D'UN ANTAGONISTE DU RÉCEPTEUR MINÉRALOCORTICOÏDE NON STÉROÏDIEN

    BAYER AG [DE] · Granted Thu Dec 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Nov 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. WO 2025252600

    COMPOSÉS ACTIVATEURS DE CANAUX POTASSIQUES KV7.2/KV7.3

    ANGELINI PHARMA S P A [IT] · Granted Thu Dec 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. AU 2025242171

    A Medicament and Method of Treatment of Central Nervous System and/or Neuropsychiatric Disorders

    BEIGENE SWITZERLAND GMBH [CH] · Granted Thu Dec 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. WO 2025252599

    COMPOSÉS ACTIVATEURS DE CANAUX POTASSIQUES KV7.2/KV7.3

    ANGELINI PHARMA S P A [IT] · Granted Thu Dec 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. WO 2025252204

    DISPERSIONS SOLIDES AMORPHES D'UN INHIBITEUR DE BRAF

    BEIGENE SUZHOU CO LTD [CN] · Granted Thu Dec 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. WO 2025252715

    AGONISTE DOUBLE DU RÉCEPTEUR DU GLP-1 ET DU GLUCAGON POUR LE TRAITEMENT DE LA MASH ET DE LA CIRRHOSE

    BOEHRINGER INGELHEIM INT [DE] · Granted Thu Dec 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. WO 2025256977

    NOUVELLES ENZYMES DE CLIVAGE IGM ET IGG

    BAYER AG [DE] · Granted Thu Dec 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 2025382344

    Soluble GLP1/GIP/NPY2 Receptor Triple Agonists

    BOEHRINGER INGELHEIM INT GMH [DE] · Granted Thu Dec 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. WO 2025259831

    FORMES CRISTALLINES D'UN ANTAGONISTE DE LPA1

    BRISTOL MYERS SQUIBB CO [US] · Granted Thu Dec 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. WO 2025260042

    CONSTRUCTIONS D'ARNI ET PROCÉDÉS D'INHIBITION DE L'EXPRESSION DE CNR1

    AMGEN INC [US] · Granted Thu Dec 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. WO 2025259749

    FRAGMENTS VARIABLES À CHAÎNE UNIQUE STABLES

    AMGEN INC [US] · Granted Thu Dec 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. WO 2025259515

    POLYTHÉRAPIE

    AMGEN INC [US] · Granted Thu Dec 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. WO 2025257278

    SÉQUENCES IMMUNOGÈNES

    BOEHRINGER INGELHEIM INT [DE] · Granted Thu Dec 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. WO 2025257199

    THÉRAPIES POUR LE TRAITEMENT DE PLAIES

    ASTRAZENECA AB [SE] · Granted Thu Dec 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 2025388678

    Methods, Combinations, and Uses for the Treatment of Muscle Invasive Bladder Cancer

    ASTRAZENECA AB [SE] · Granted Thu Dec 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. WO 2025265110

    COMPOSITIONS PHARMACEUTIQUES ORALES RENFERMANT UN COMPOSÉ DE NAPHTYRIDINE

    AMGEN INC [US] · Granted Fri Dec 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Thu Dec 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. WO 2025261951

    POLYTHÉRAPIE AVEC UN ANTICORPS ANTI-CA19-9 ET DU FOLFIRINOX DANS LE TRAITEMENT DU CANCER

    BIONTECH SE [DE] · Granted Fri Dec 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Thu Dec 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. WO 2025262130

    CONJUGUÉ ANTICORPS-MÉDICAMENT

    BIONTECH SE [DE] · Granted Fri Dec 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Thu Dec 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. WO 2025262150

    MOLÉCULES DE RECRUTEMENT D'ANTICORPS

    ABLYNX NV [BE] · Granted Fri Dec 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Thu Dec 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. WO 2025262460

    COMPOSITIONS LIPIDIQUES POUR L'ADMINISTRATION D'ACIDES NUCLÉIQUES

    BIONTECH SE [DE] · Granted Fri Dec 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Thu Dec 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. WO 2025264662

    COMPOSITIONS ET MÉTHODES DE TRAITEMENT D'UN MÉLANOME

    BIONTECH SE [DE] · Granted Fri Dec 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Thu Dec 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. WO 2025265012

    COMPOSITIONS COMPRENANT DES ANTICORPS ANTI-PCSK9

    AMGEN INC [US] · Granted Fri Dec 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Thu Dec 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. WO 2025260285

    CONJUGUÉ ANTICORPS-MÉDICAMENT

    DUALITY BIOLOGICS SUZHOU CO LTD [CN] · Granted Fri Dec 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Thu Dec 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. WO 2025261607

    PARTICULES, COMPOSITIONS ET PROCÉDÉS

    BIONTECH SE [DE] · Granted Fri Dec 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Thu Dec 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. EP 4670742

    ANTI-CD79B-ANTIKÖRPER-WIRKSTOFFKONJUGATE

    ABBVIE INC [US] · Granted Wed Dec 31 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Dec 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 20260001878

    SUBSTITUTED PYRROLOPYRIDINE COMPOUNDS USEFUL AS INHIBITORS OF TLR9

    BRISTOL MYERS SQUIBB CO [US] · Granted Thu Jan 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. WO 2026006398

    RÉDUCTASES D'IMINE MODIFIÉES ET LEURS PROCÉDÉS D'UTILISATION

    AMGEN INC [US] · Granted Fri Jan 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Thu Dec 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. WO 2026006803

    COMPOSÉS À NOYAU À 5 CHAÎNONS UTILISÉS EN TANT QUE MODULATEURS DE L'HÉLICASE D'ADN RECQ DU SYNDROME DE WERNER ET LEURS UTILISATIONS

    AMGEN INC [US] · Granted Fri Jan 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Thu Dec 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. WO 2026006805

    COMPOSÉS À NOYAU À 6 CHAÎNONS UTILISÉS COMME MODULATEURS DE L'HÉLICASE À ADN RECQ DU SYNDROME DE WERNER ET LEURS UTILISATIONS

    AMGEN INC [US] · Granted Fri Jan 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Thu Dec 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. WO 2026006232

    COMPOSITION EFFERVESCENTE ORALE

    BAYER HEALTHCARE LLC [US] · Granted Fri Jan 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Thu Dec 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2045?

1,566 published patents in our USPTO index have expiration dates falling in calendar year 2045.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.